That company suing Patrick Soon-Shiong for $1B? Someone's trying to buy it for $1B
Someone is trying to buy Sorrento Therapeutics.
After years of watching its ticker decline dramatically, the Patrick Soon-Shiong partner-turned-plaintiff has received an offer from a private equity firm worth twice its stock price. The offer would pay $7 per stock, or roughly $1.15 billion.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 84,700+ biopharma pros reading Endpoints daily — and it's free.